Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients

被引:0
作者
Jing Wu
Yuerong Han
Fei-Li Zhao
Jin Zhou
Zhijun Chen
He Sun
机构
[1] Tianjin University,School of Pharmaceutical Science and Technology
[2] University of Newcastle,Clinical Pharmacology and Toxicology
[3] Tianjin Chest Hospital,undefined
[4] Affiliated Hospital of Logistics University of Chinese People's Armed Police Force,undefined
来源
Health and Quality of Life Outcomes | / 12卷
关键词
Quality of life; Stable angina; EQ-5D; SF-6D; Utility; China;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 210 条
[1]  
Earnshaw J(2008)NICE guide to the methods of technology appraisal: pharmaceutical industry perspective Pharmacoeconomics 26 725-727
[2]  
Lewis G(2001)AMCP guidance for submission of clinical and economic evaluation data to support formulary listing in U.S. health plans and pharmacy benefits J Manag Care Pharm 7 272-282
[3]  
Sullivan SD(2003)A comparative review of four preference-weighted measures of health-related quality of life J Clin Epidemiol 56 317-325
[4]  
Lyles A(2000)Preference-based measures in economic evaluation in health care Annu Rev Public Health 21 587-611
[5]  
Luce B(1976)Health status: types of validity and the index of wellbeing Health Serv Res 11 478-507
[6]  
Grigar J(1995)Multi-attribute preference functions. Health utilities index Pharmacoeconomics 7 503-520
[7]  
Kopec JA(2001)EQ-5D: a measure of health status from the EuroQol Group Ann Med 33 337-343
[8]  
Willison KD(2001)A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments Ann Med 33 358-370
[9]  
Neumann PJ(2002)The estimation of a preference-based measure of health from the SF-36 J Health Econ 21 271-292
[10]  
Goldie SJ(2012)Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies PLoS One 7 e31115-604